Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical immunotherapy in dermatology.

D A Buckley1, A W du Vivier

  • 1Department of Dermatology, King's College Hospital, London, UK.

International Journal of Clinical Practice
|May 27, 1999
PubMed
Summary

Topical immunotherapy using diphencyprone (DCP) offers an effective treatment for severe alopecia areata and resistant warts. Careful handling and supervision minimize risks, making DCP a valuable option for these challenging skin conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous myiasis misdiagnosed as an abdominal abscess.

Clinical and experimental dermatology·2021
Same author

Sudocrem<sup>®</sup> dermatitis: easily missed.

Clinical and experimental dermatology·2021
Same author

Current prevalence and relevance of positive patch test reactions to cosmetic and noncosmetic isothiazolinones in the UK.

The British journal of dermatology·2021
Same author

Occupational dermatoses during the COVID-19 pandemic: a multicentre audit in the UK and Ireland.

The British journal of dermatology·2020
Same author

Prevalence of allergic contact dermatitis to decyl and lauryl glucoside in the UK and Ireland.

The British journal of dermatology·2020
Same author

What is in? What is out? Updating the British Society for Cutaneous Allergy facial series.

The British journal of dermatology·2020

Area of Science:

  • Dermatology
  • Immunology
  • Contact Sensitization

Background:

  • Topical immunotherapy has been utilized for skin diseases since the 1970s.
  • Conditions treated include alopecia areata and viral warts, often linked to altered immune states.
  • Limited UK dermatology departments currently offer this treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety of topical immunotherapy for specific skin conditions.
  • To compare diphencyprone (DCP) with other contact sensitizers like DNCB and SADBE.
  • To highlight DCP as a preferred agent for topical immunotherapy.

Main Methods:

  • Application of universal contact sensitizers, primarily diphencyprone (DCP).
  • Careful handling protocols to prevent staff sensitization.
  • Close patient supervision during treatment.

Main Results:

  • Diphencyprone (DCP) demonstrates advantages over dinitrochlorobenzene (DNCB) and squaric acid dibutyl ester (SADBE).
  • Common side effects include local blistering and eczematous reactions.
  • Rare complications such as vitiligo and erythema multiforme-like reactions were noted.

Conclusions:

  • Topical immunotherapy with DCP is a viable and effective treatment for severe alopecia areata and resistant viral warts.
  • Close medical supervision is crucial for managing treatment risks.
  • DCP presents a beneficial option in the management of these dermatological conditions.

Related Experiment Videos